Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06181396 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 26, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
Trial Details
NCT Number NCT06181396
Lead Sponsor Rambam Health Care Campus
Conditions
(from sponsor)		 Delivery Complication, Cesarean Delivery Affecting Fetus
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov